Derm Cases · General Medicine
OSCE — Viral Warts (Verrucae)
Eight-minute OSCE station on Viral Warts (Verrucae): focused history, examination priorities, investigations, emergency and definitive management.
On this page
Study tools
Target exams
Brief (to candidate)
You will assess a patient with a presentation consistent with Viral Warts (Verrucae).
You have 8 minutes to take a focused history, outline examination, investigations, and management including red flags.
Clinical context
Viral warts (verrucae) are benign epidermal proliferations caused by human papillomavirus (HPV) infection of basal keratinocytes. Clinical subtypes: common (verruca vulgaris) — rough, hyperkeratotic papules on hands, fingers and knees (HPV 1, 2, 4, 27); plantar (verruca plantaris/myrmecia) — tender, inward-growing on soles with pathognomonic black dots that are thrombosed capillary loops (HPV 1); flat (verruca plana) — smooth, flat-topped papules on face and hands (HPV 3, 10, 28); filiform — finger-like projections on face and neck; genital (condyloma acuminata) — sexually transmitted cauliflower-like lesions (HPV 6, 11; oncogenic 16, 18, 31, 33). Most cutaneous warts resolve spontaneously i
[2]Candidate tasks
- Clarify onset, severity, associated features, and red-flag symptoms.
- State focused examination priorities.
- List first-line investigations and any named score/criteria.
- Give immediate resuscitation steps.
- Outline definitive management with doses/routes where standard.
- Name complications and disposition (ward / HDU / theatre / discharge safety-net).
- Mention one special-population modifier (pregnancy, child, elderly, CKD).
Examiner checklist
| Domain | Pass behaviours |
|---|---|
| Definition | Correct working diagnosis language |
| Assessment | Focused, prioritised, red flags sought |
| Investigations | Appropriate first-line + interpretation |
| Emergency care | ABC / time-critical actions first |
| Definitive care | Specific drugs/procedures, not generic phrases |
| Safety | Persistent, enlarging or atypical wart-like lesion — biopsy to exclude squamous |
| Safety | Rapidly proliferating or giant genital warts — screen for HIV; consider Buschke- |
| Safety | Periungual wart with nail dystrophy — risk of permanent matrix damage; treat ear |
| Communication | Clear plan and safety-netting |
Model outline
Lead with the working diagnosis and life threats. Resuscitate before definitive tests when unstable. Use guideline-standard therapy with named agents and doses. Document escalation criteria and follow-up. A safe candidate is specific, structured, and never delays critical care for non-urgent imaging.[2]
References2ShowHide
- [1]Leerunyakul K, Thammarucha S, Suchonwanit P, Rutnin S. A comprehensive review of treatment options for recalcitrant nongenital cutaneous warts J Dermatolog Treat, 2022.PMID 32116076
- [2]Gilson R, Nugent D, Bennett K, et al. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT Health Technol Assess, 2020.PMID 32975189